1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs

BACKGROUND: Current IDSA guidelines for the treatment of UTIs discourage oral β-lactams based on lack of adequately powered studies to assess efficacy compared to fluoroquinolones or TMP-SMX. However, increasing E. coli and Klebsiella spp. resistance to first-line antibiotics has necessitated the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Benning, Molly, Acosta, Dominic, Sarangarm, Preeyaporn, Walraven, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643744/
http://dx.doi.org/10.1093/ofid/ofab466.1617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643744/
http://dx.doi.org/10.1093/ofid/ofab466.1617

Ejemplares similares